Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Atreca Inc BCEL

Alternate Symbol(s):  COLUF

Atreca, Inc. is a clinical-stage biopharmaceutical company. The Company is discovering and developing antibody-based therapeutics to treat a range of solid tumor types. Its most advanced product candidate, ATRC-101, is a monoclonal antibody with a mechanism of action and target derived from an antibody identified using its discovery platform. ATRC-101 reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal and breast cancer samples from multiple patients. It commenced clinical development of ATRC-101 with a Phase Ib clinical trial evaluating ATRC-101 as a monotherapy in patients with select solid tumors and opens a new cohort to evaluate ATRC-101 in combination with pembrolizumab, a PD-1 checkpoint inhibitor. It is also advancing additional product candidates using its discovery platform. Its oncology programs include APN-497444, an ADC against a tumor glycan target, and APN-346958, a CD3 bispecific T-cell engager against an RNA-binding protein target.


PINL:BCEL - Post by User

Bullboard Posts
Comment by TheHoboon Apr 15, 2010 10:25am
374 Views
Post# 16994560

RE: Technical Analyis For Lobstertits

RE: Technical Analyis For LobstertitsWell shucks Stockhouse doesn't like pastings with pictures so here's the text:

  • The 20 and 50 day moving averages indicate that CSI may be in a bullish trend. This is because the 20 day moving average is above the 50 day moving average.
  • CSI is trading above its 20 day moving average. This is considered to be the sign of a bullish trend. There is added weight to this indication because the moving average is rising and signals that there has been buying interest in this stock.
  • CSI is trading near its upper Bollinger Band. This means that the stock price is high relative to the action over the last 20 days.
  • The MACD is presently offering a bullish signal because it is above the signal line, a 9 day moving average, and higher than 0, which means that the underlying moving averages are trending higher.
  • The On Balance Volume indicator (OBV) presently offers a bullish signal. This is because the slope of the indicator is positive and shows that there is considerable buying interest.

If you base your comments on RSI/OSC only, well, you need to stop investing (since clearly you aren't very good at it) and maybe take up professional basket weaving?  Anyways hang around for awhile.. You're my good luck charm pumpkin.

Bullboard Posts